Alopecia Market Growth & Trends
The global alopecia market size is expected to reach USD 16.02 billion by 2030, registering a CAGR of 8.7% from 2025 to 2030. The approval of JAK inhibitors and tyrosine kinase inhibitors along with the rising target disease prevalence is expected to drive market growth.
The prevalence of alopecia areata (AA) and alopecia to talis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.
The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly’s Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer’s Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.
Another key factor driving the industry’s growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.
The limited availability of targeted drugs that treat the underlying condition is one key challenge for the market. While new products with targeted mechanisms of action are being approved the high cost of these drugs in comparison to the already approved products is one of the major hindrances in their widespread adoption.
Alopecia Market Report Highlights
- The alopecia universalis segment is expected to witness the fastest growth from 2025 to 2030, owing to the impending approval of pipeline products, such as Pfizer’s Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics’s BNZ-1 which is in phase 2 clinical trials
- North America dominated the market in 2024, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
- Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Type
1.2.2. Treatment
1.2.3. Gender
1.2.4. Sales Channel
1.2.5. End Use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Disease Type
1.2.2. Treatment
1.2.3. Gender
1.2.4. Sales Channel
1.2.5. End Use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease Type
2.2.2. Treatment
2.2.3. Gender
2.2.4. Sales Channel
2.2.5. End Use
2.2.6. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Disease Type
2.2.2. Treatment
2.2.3. Gender
2.2.4. Sales Channel
2.2.5. End Use
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Alopecia Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing global prevalence of alopecia
3.2.1.2. Increasing global healthcare expenditure
3.2.1.3. Increasing prevalence of chronic diseases
3.2.1.3.1. PCOS
3.2.1.3.2. Cancer
3.2.1.3.3. Rheumatoid Arthritis
3.2.1.4. Technological advancements in alopecia treatment
3.2.2. Market restraint analysis
3.2.2.1. Lack of reimbursement policies for alopecia treatment
3.2.2.2. Increasing adoption of substitutes
3.3. Alopecia Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Patent Expiry Analysis
3.5. Pipeline Analysis
3.5.1. Phase 1
3.5.2. Phase 2
3.5.3. Phase 3
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing global prevalence of alopecia
3.2.1.2. Increasing global healthcare expenditure
3.2.1.3. Increasing prevalence of chronic diseases
3.2.1.3.1. PCOS
3.2.1.3.2. Cancer
3.2.1.3.3. Rheumatoid Arthritis
3.2.1.4. Technological advancements in alopecia treatment
3.2.2. Market restraint analysis
3.2.2.1. Lack of reimbursement policies for alopecia treatment
3.2.2.2. Increasing adoption of substitutes
3.3. Alopecia Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Patent Expiry Analysis
3.5. Pipeline Analysis
3.5.1. Phase 1
3.5.2. Phase 2
3.5.3. Phase 3
Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis
4.1. Disease Type Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Alopecia Market by Disease Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Alopecia Areata
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Male
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Female
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Cicatricial Alopecia
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Male
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Female
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Traction Alopecia
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Male
4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Female
4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Alopecia Totalis
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Male
4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Female
4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Alopecia Universalis
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.2. Male
4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.3. Female
4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Androgenetic Alopecia
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.2. Male
4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.3. Female
4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.2. Male
4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.3. Female
4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Alopecia Market by Disease Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Alopecia Areata
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Male
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Female
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Cicatricial Alopecia
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Male
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Female
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Traction Alopecia
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Male
4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Female
4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Alopecia Totalis
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Male
4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Female
4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Alopecia Universalis
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.2. Male
4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.3. Female
4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Androgenetic Alopecia
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.2. Male
4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.3. Female
4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.2. Male
4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.3. Female
4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Alopecia Market: Treatment Estimates & Trend Analysis
5.1. Treatment Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Alopecia Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Pharmaceuticals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Topical
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2. OTC
5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.2. Minoxidil
5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.3. Others
5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3. Prescription
5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.2. Betamethasone Dipropionate
5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.3. Fluocinolone Acetonide
5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.4. Finasteride
5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.5. Minoxidil
5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Oral
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.2. OTC
5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3. Prescription
5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.2. Minoxidil
5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.3. Finasteride
5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.4. Corticosteroids
5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.5. Others (JAK inhibitors and others)
5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. PRP
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Devices
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Laser Cap
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.2. Laser Comb
5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.4. Laser Helmet
5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Segment Dashboard
5.3. Global Alopecia Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Pharmaceuticals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Topical
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2. OTC
5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.2. Minoxidil
5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.3. Others
5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3. Prescription
5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.2. Betamethasone Dipropionate
5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.3. Fluocinolone Acetonide
5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.4. Finasteride
5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.5. Minoxidil
5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Oral
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.2. OTC
5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3. Prescription
5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.2. Minoxidil
5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.3. Finasteride
5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.4. Corticosteroids
5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.5. Others (JAK inhibitors and others)
5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. PRP
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Devices
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Laser Cap
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.2. Laser Comb
5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.4. Laser Helmet
5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Alopecia Market: Gender Estimates & Trend Analysis
6.1. Gender Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Alopecia Market by Gender Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Male
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Female
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Segment Dashboard
6.3. Global Alopecia Market by Gender Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Male
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Female
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Alopecia Market: Sales Channel Estimates & Trend Analysis
7.1. Sales Channel Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global Alopecia Market by Gender Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Prescription
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. OTC
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Segment Dashboard
7.3. Global Alopecia Market by Gender Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Prescription
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. OTC
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Alopecia Market: End Use Estimates & Trend Analysis
8.1. End Use Market Share, 2024 & 2030
8.2. Segment Dashboard
8.3. Global Alopecia Market by End Use Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Homecare Settings
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Dermatology Clinics
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.2. Segment Dashboard
8.3. Global Alopecia Market by End Use Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Homecare Settings
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Dermatology Clinics
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Alopecia Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Argentina
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Argentina
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. Key company market share analysis, 2024
10.3.2. Janssen Global Services Inc.
10.3.2.1. Company overview
10.3.2.2. Financial performance
10.3.2.3. Product benchmarking
10.3.2.4. Strategic initiatives
10.3.3. Cipla
10.3.3.1. Company overview
10.3.3.2. Financial performance
10.3.3.3. Product benchmarking
10.3.3.4. Strategic initiatives
10.3.4. Merck & Co., Inc.
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. GSK plc
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Sun Pharmaceuticals Industries Ltd
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Dr. Reddy’s Laboratories Ltd
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Aurobindo Pharma
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Viatris Inc.
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Pfizer, Inc.
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Eli Lilly and Company
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Lexington Intl., LLC (Devices)
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Freedom Laser Therapy (iRestore ID-520 helmet)
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Curallux, LLC.
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Apira Science Inc. (iGROW Laser)
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Revian Inc.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Theradome
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Lutronic
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. Key company market share analysis, 2024
10.3.2. Janssen Global Services Inc.
10.3.2.1. Company overview
10.3.2.2. Financial performance
10.3.2.3. Product benchmarking
10.3.2.4. Strategic initiatives
10.3.3. Cipla
10.3.3.1. Company overview
10.3.3.2. Financial performance
10.3.3.3. Product benchmarking
10.3.3.4. Strategic initiatives
10.3.4. Merck & Co., Inc.
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. GSK plc
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Sun Pharmaceuticals Industries Ltd
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Dr. Reddy’s Laboratories Ltd
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Aurobindo Pharma
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Viatris Inc.
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Pfizer, Inc.
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Eli Lilly and Company
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Lexington Intl., LLC (Devices)
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Freedom Laser Therapy (iRestore ID-520 helmet)
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Curallux, LLC.
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Apira Science Inc. (iGROW Laser)
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Revian Inc.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Theradome
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Lutronic
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America alopecia market, by region, 2018 - 2030 (USD Million)
Table 3 North America alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 4 North America alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 5 North America alopecia market, by gender, 2018 - 2030 (USD Million)
Table 6 North America alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 7 North America alopecia market, by end use, 2018 - 2030 (USD Million)
Table 8 U.S. alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 9 U.S. alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 10 U.S. alopecia market, by gender, 2018 - 2030 (USD Million)
Table 11 U.S. alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 12 U.S. alopecia market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 14 Canada alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 15 Canada alopecia market, by gender, 2018 - 2030 (USD Million)
Table 16 Canada alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 17 Canada alopecia market, by end use, 2018 - 2030 (USD Million)
Table 18 Mexico alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 19 Mexico alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 20 Mexico alopecia market, by gender, 2018 - 2030 (USD Million)
Table 21 Mexico alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 22 Mexico alopecia market, by end use, 2018 - 2030 (USD Million)
Table 23 Europe alopecia market, by region, 2018 - 2030 (USD Million)
Table 24 Europe alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 25 Europe alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 26 Europe alopecia market, by gender, 2018 - 2030 (USD Million)
Table 27 Europe alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 28 Europe alopecia market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 30 Germany alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 31 Germany alopecia market, by gender, 2018 - 2030 (USD Million)
Table 32 Germany alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 33 Germany alopecia market, by end use, 2018 - 2030 (USD Million)
Table 34 UK alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 35 UK alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 36 UK alopecia market, by gender, 2018 - 2030 (USD Million)
Table 37 UK alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 38 UK alopecia market, by end use, 2018 - 2030 (USD Million)
Table 39 France alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 40 France alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 41 France alopecia market, by gender, 2018 - 2030 (USD Million)
Table 42 France alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 43 France alopecia market, by end use, 2018 - 2030 (USD Million)
Table 44 Italy alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 45 Italy alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 46 Italy alopecia market, by gender, 2018 - 2030 (USD Million)
Table 47 Italy alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 48 Italy alopecia market, by end use, 2018 - 2030 (USD Million)
Table 49 Spain alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 50 Spain alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 51 Spain alopecia market, by gender, 2018 - 2030 (USD Million)
Table 52 Spain alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 53 Spain alopecia market, by end use, 2018 - 2030 (USD Million)
Table 54 Denmark alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 55 Denmark alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 56 Denmark alopecia market, by gender, 2018 - 2030 (USD Million)
Table 57 Denmark alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 58 Denmark alopecia market, by end use, 2018 - 2030 (USD Million)
Table 59 Sweden alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 60 Sweden alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 61 Sweden alopecia market, by gender, 2018 - 2030 (USD Million)
Table 62 Sweden alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 63 Sweden alopecia market, by end use, 2018 - 2030 (USD Million)
Table 64 Norway alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 65 Norway alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 66 Norway alopecia market, by gender, 2018 - 2030 (USD Million)
Table 67 Norway alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 68 Norway alopecia market, by end use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific alopecia market, by region, 2018 - 2030 (USD Million)
Table 70 Asia Pacific alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 71 Asia Pacific alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 72 Asia Pacific alopecia market, by gender, 2018 - 2030 (USD Million)
Table 73 Asia Pacific alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 74 Asia Pacific alopecia market, by end use, 2018 - 2030 (USD Million)
Table 75 China alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 76 China alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 77 China alopecia market, by gender, 2018 - 2030 (USD Million)
Table 78 China alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 79 China alopecia market, by end use, 2018 - 2030 (USD Million)
Table 80 Japan alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 81 Japan alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 82 Japan alopecia market, by gender, 2018 - 2030 (USD Million)
Table 83 Japan alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 84 Japan alopecia market, by end use, 2018 - 2030 (USD Million)
Table 85 India alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 86 India alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 87 India alopecia market, by gender, 2018 - 2030 (USD Million)
Table 88 India alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 89 India alopecia market, by end use, 2018 - 2030 (USD Million)
Table 90 South Korea alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 91 South Korea alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 92 South Korea alopecia market, by gender, 2018 - 2030 (USD Million)
Table 93 South Korea alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 94 South Korea alopecia market, by end use, 2018 - 2030 (USD Million)
Table 95 Australia alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 96 Australia alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 97 Australia alopecia market, by gender, 2018 - 2030 (USD Million)
Table 98 Australia alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 99 Australia alopecia market, by end use, 2018 - 2030 (USD Million)
Table 100 Thailand alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 101 Thailand alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 102 Thailand alopecia market, by gender, 2018 - 2030 (USD Million)
Table 103 Thailand alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 104 Thailand alopecia market, by end use, 2018 - 2030 (USD Million)
Table 105 Latin America alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 106 Latin America alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 107 Latin America alopecia market, by gender, 2018 - 2030 (USD Million)
Table 108 Latin America alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 109 Latin America alopecia market, by end use, 2018 - 2030 (USD Million)
Table 110 Brazil alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 111 Brazil alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 112 Brazil alopecia market, by gender, 2018 - 2030 (USD Million)
Table 113 Brazil alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 114 Brazil alopecia market, by end use, 2018 - 2030 (USD Million)
Table 115 Argentina alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 116 Argentina alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 117 Argentina alopecia market, by gender, 2018 - 2030 (USD Million)
Table 118 Argentina alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 119 Argentina alopecia market, by end use, 2018 - 2030 (USD Million)
Table 120 MEA alopecia market, by region, 2018 - 2030 (USD Million)
Table 121 MEA alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 122 MEA alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 123 MEA alopecia market, by gender, 2018 - 2030 (USD Million)
Table 124 MEA alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 125 MEA alopecia market, by end use, 2018 - 2030 (USD Million)
Table 126 South Africa alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 127 South Africa alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 128 South Africa alopecia market, by gender, 2018 - 2030 (USD Million)
Table 129 South Africa alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 130 South Africa alopecia market, by end use, 2018 - 2030 (USD Million)
Table 131 Saudi Arabia alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia alopecia market, by gender, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia alopecia market, by end use, 2018 - 2030 (USD Million)
Table 136 UAE alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 137 UAE alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 138 UAE alopecia market, by gender, 2018 - 2030 (USD Million)
Table 139 UAE alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 140 UAE alopecia market, by end use, 2018 - 2030 (USD Million)
Table 141 Kuwait alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 142 Kuwait alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 143 Kuwait alopecia market, by gender, 2018 - 2030 (USD Million)
Table 144 Kuwait alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 145 Kuwait alopecia market, by end use, 2018 - 2030 (USD Million)
Table 2 North America alopecia market, by region, 2018 - 2030 (USD Million)
Table 3 North America alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 4 North America alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 5 North America alopecia market, by gender, 2018 - 2030 (USD Million)
Table 6 North America alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 7 North America alopecia market, by end use, 2018 - 2030 (USD Million)
Table 8 U.S. alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 9 U.S. alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 10 U.S. alopecia market, by gender, 2018 - 2030 (USD Million)
Table 11 U.S. alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 12 U.S. alopecia market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 14 Canada alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 15 Canada alopecia market, by gender, 2018 - 2030 (USD Million)
Table 16 Canada alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 17 Canada alopecia market, by end use, 2018 - 2030 (USD Million)
Table 18 Mexico alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 19 Mexico alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 20 Mexico alopecia market, by gender, 2018 - 2030 (USD Million)
Table 21 Mexico alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 22 Mexico alopecia market, by end use, 2018 - 2030 (USD Million)
Table 23 Europe alopecia market, by region, 2018 - 2030 (USD Million)
Table 24 Europe alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 25 Europe alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 26 Europe alopecia market, by gender, 2018 - 2030 (USD Million)
Table 27 Europe alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 28 Europe alopecia market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 30 Germany alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 31 Germany alopecia market, by gender, 2018 - 2030 (USD Million)
Table 32 Germany alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 33 Germany alopecia market, by end use, 2018 - 2030 (USD Million)
Table 34 UK alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 35 UK alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 36 UK alopecia market, by gender, 2018 - 2030 (USD Million)
Table 37 UK alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 38 UK alopecia market, by end use, 2018 - 2030 (USD Million)
Table 39 France alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 40 France alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 41 France alopecia market, by gender, 2018 - 2030 (USD Million)
Table 42 France alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 43 France alopecia market, by end use, 2018 - 2030 (USD Million)
Table 44 Italy alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 45 Italy alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 46 Italy alopecia market, by gender, 2018 - 2030 (USD Million)
Table 47 Italy alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 48 Italy alopecia market, by end use, 2018 - 2030 (USD Million)
Table 49 Spain alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 50 Spain alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 51 Spain alopecia market, by gender, 2018 - 2030 (USD Million)
Table 52 Spain alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 53 Spain alopecia market, by end use, 2018 - 2030 (USD Million)
Table 54 Denmark alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 55 Denmark alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 56 Denmark alopecia market, by gender, 2018 - 2030 (USD Million)
Table 57 Denmark alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 58 Denmark alopecia market, by end use, 2018 - 2030 (USD Million)
Table 59 Sweden alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 60 Sweden alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 61 Sweden alopecia market, by gender, 2018 - 2030 (USD Million)
Table 62 Sweden alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 63 Sweden alopecia market, by end use, 2018 - 2030 (USD Million)
Table 64 Norway alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 65 Norway alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 66 Norway alopecia market, by gender, 2018 - 2030 (USD Million)
Table 67 Norway alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 68 Norway alopecia market, by end use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific alopecia market, by region, 2018 - 2030 (USD Million)
Table 70 Asia Pacific alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 71 Asia Pacific alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 72 Asia Pacific alopecia market, by gender, 2018 - 2030 (USD Million)
Table 73 Asia Pacific alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 74 Asia Pacific alopecia market, by end use, 2018 - 2030 (USD Million)
Table 75 China alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 76 China alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 77 China alopecia market, by gender, 2018 - 2030 (USD Million)
Table 78 China alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 79 China alopecia market, by end use, 2018 - 2030 (USD Million)
Table 80 Japan alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 81 Japan alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 82 Japan alopecia market, by gender, 2018 - 2030 (USD Million)
Table 83 Japan alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 84 Japan alopecia market, by end use, 2018 - 2030 (USD Million)
Table 85 India alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 86 India alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 87 India alopecia market, by gender, 2018 - 2030 (USD Million)
Table 88 India alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 89 India alopecia market, by end use, 2018 - 2030 (USD Million)
Table 90 South Korea alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 91 South Korea alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 92 South Korea alopecia market, by gender, 2018 - 2030 (USD Million)
Table 93 South Korea alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 94 South Korea alopecia market, by end use, 2018 - 2030 (USD Million)
Table 95 Australia alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 96 Australia alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 97 Australia alopecia market, by gender, 2018 - 2030 (USD Million)
Table 98 Australia alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 99 Australia alopecia market, by end use, 2018 - 2030 (USD Million)
Table 100 Thailand alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 101 Thailand alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 102 Thailand alopecia market, by gender, 2018 - 2030 (USD Million)
Table 103 Thailand alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 104 Thailand alopecia market, by end use, 2018 - 2030 (USD Million)
Table 105 Latin America alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 106 Latin America alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 107 Latin America alopecia market, by gender, 2018 - 2030 (USD Million)
Table 108 Latin America alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 109 Latin America alopecia market, by end use, 2018 - 2030 (USD Million)
Table 110 Brazil alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 111 Brazil alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 112 Brazil alopecia market, by gender, 2018 - 2030 (USD Million)
Table 113 Brazil alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 114 Brazil alopecia market, by end use, 2018 - 2030 (USD Million)
Table 115 Argentina alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 116 Argentina alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 117 Argentina alopecia market, by gender, 2018 - 2030 (USD Million)
Table 118 Argentina alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 119 Argentina alopecia market, by end use, 2018 - 2030 (USD Million)
Table 120 MEA alopecia market, by region, 2018 - 2030 (USD Million)
Table 121 MEA alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 122 MEA alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 123 MEA alopecia market, by gender, 2018 - 2030 (USD Million)
Table 124 MEA alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 125 MEA alopecia market, by end use, 2018 - 2030 (USD Million)
Table 126 South Africa alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 127 South Africa alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 128 South Africa alopecia market, by gender, 2018 - 2030 (USD Million)
Table 129 South Africa alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 130 South Africa alopecia market, by end use, 2018 - 2030 (USD Million)
Table 131 Saudi Arabia alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia alopecia market, by gender, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia alopecia market, by end use, 2018 - 2030 (USD Million)
Table 136 UAE alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 137 UAE alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 138 UAE alopecia market, by gender, 2018 - 2030 (USD Million)
Table 139 UAE alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 140 UAE alopecia market, by end use, 2018 - 2030 (USD Million)
Table 141 Kuwait alopecia market, by disease type, 2018 - 2030 (USD Million)
Table 142 Kuwait alopecia market, by treatment, 2018 - 2030 (USD Million)
Table 143 Kuwait alopecia market, by gender, 2018 - 2030 (USD Million)
Table 144 Kuwait alopecia market, by sales channel, 2018 - 2030 (USD Million)
Table 145 Kuwait alopecia market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alopecia market: market outlook
Fig. 14 Alopecia competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alopecia market driver impact
Fig. 20 Alopecia market restraint impact
Fig. 21 Alopecia market strategic initiatives analysis
Fig. 22 Alopecia market: Disease type movement analysis
Fig. 23 Alopecia market: Disease type outlook and key takeaways
Fig. 24 Alopecia areata market estimates and forecast, 2018 - 2030
Fig. 25 Male alopecia areata market estimates and forecast, 2018 - 2030
Fig. 26 Female alopecia areata market estimates and forecast, 2018 - 2030
Fig. 27 Cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 30 Traction alopecia market estimates and forecast, 2018 - 2030
Fig. 31 Male traction market estimates and forecast, 2018 - 2030
Fig. 32 Female traction market estimates and forecast, 2018 - 2030
Fig. 33 Alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 34 Male alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 35 Female alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 36 Alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 37 Male alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 38 Female alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 39 Androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 42 Other alopecia market estimates and forecast, 2018 - 2030
Fig. 43 Male other alopecia market estimates and forecast, 2018 - 2030
Fig. 44 Female other alopecia market estimates and forecast, 2018 - 2030
Fig. 45 Alopecia Market: Treatment movement Analysis
Fig. 46 Alopecia market: Treatment outlook and key takeaways
Fig. 47 Pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 48 Topical market estimates and forecasts, 2018 - 2030
Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 50 Topical OTC minoxidil market estimates and forecasts, 2018 - 2030
Fig. 51 Topical OTC others market estimates and forecasts, 2018 - 2030
Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts, 2018 - 2030
Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts, 2018 - 2030
Fig. 55 Topical prescription finasteride market estimates and forecasts, 2018 - 2030
Fig. 56 Topical prescription minoxidil market estimates and forecasts, 2018 - 2030
Fig. 57 Oral pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 60 Oral prescription minoxidil market estimates and forecasts, 2018 - 2030
Fig. 61 Oral prescription finasteride market estimates and forecasts, 2018 - 2030
Fig. 62 Oral prescription corticosteroids market estimates and forecasts, 2018 - 2030
Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts, 2018 - 2030
Fig. 64 PRP market estimates and forecasts, 2018 - 2030
Fig. 65 Devices market estimates and forecasts, 2018 - 2030
Fig. 66 Laser cap market estimates and forecasts, 2018 - 2030
Fig. 67 Laser comb market estimates and forecasts, 2018 - 2030
Fig. 68 Laser helmet market estimates and forecasts, 2018 - 2030
Fig. 69 Alopecia market: Gender movement analysis
Fig. 70 Alopecia market: Gender outlook and key takeaways
Fig. 71 Male market estimates and forecasts, 2018 - 2030
Fig. 72 Female market estimates and forecasts, 2018 - 2030
Fig. 73 Alopecia market: Sales channel movement analysis
Fig. 74 Alopecia market: Sales channel outlook and key takeaways
Fig. 75 Prescriptions market estimates and forecasts, 2018 - 2030
Fig. 76 OTC market estimates and forecasts, 2018 - 2030
Fig. 77 Alopecia market: End use movement analysis
Fig. 78 Alopecia market: End use outlook and key takeaways
Fig. 79 Homecare settings market estimates and forecasts, 2018 - 2030
Fig. 80 Dermatology clinics market estimates and forecasts, 2018 - 2030
Fig. 81 Global alopecia market: Regional movement analysis
Fig. 82 Global alopecia market: Regional outlook and key takeaways
Fig. 83 North America
Fig. 84 North America market estimates and forecasts, 2018 - 2030
Fig. 85 U.S.
Fig. 86 U.S. market estimates and forecasts, 2018 - 2030
Fig. 87 Canada
Fig. 88 Canada market estimates and forecasts, 2018 - 2030
Fig. 89 Mexico
Fig. 90 Mexico market estimates and forecasts, 2018 - 2030
Fig. 91 Europe
Fig. 92 Europe market estimates and forecasts, 2018 - 2030
Fig. 93 UK
Fig. 94 UK market estimates and forecasts, 2018 - 2030
Fig. 95 Germany
Fig. 96 Germany market estimates and forecasts, 2018 - 2030
Fig. 97 France
Fig. 98 France market estimates and forecasts, 2018 - 2030
Fig. 99 Italy
Fig. 100 Italy market estimates and forecasts, 2018 - 2030
Fig. 101 Spain
Fig. 102 Spain market estimates and forecasts, 2018 - 2030
Fig. 103 Denmark
Fig. 104 Denmark market estimates and forecasts, 2018 - 2030
Fig. 105 Sweden
Fig. 106 Sweden market estimates and forecasts, 2018 - 2030
Fig. 107 Norway
Fig. 108 Norway market estimates and forecasts, 2018 - 2030
Fig. 109 Asia Pacific
Fig. 110 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 111 China
Fig. 112 China market estimates and forecasts, 2018 - 2030
Fig. 113 Japan
Fig. 114 Japan market estimates and forecasts, 2018 - 2030
Fig. 115 India
Fig. 116 India market estimates and forecasts, 2018 - 2030
Fig. 117 Thailand
Fig. 118 Thailand market estimates and forecasts, 2018 - 2030
Fig. 119 South Korea
Fig. 120 South Korea market estimates and forecasts, 2018 - 2030
Fig. 121 Australia
Fig. 122 Australia market estimates and forecasts, 2018 - 2030
Fig. 123 Latin America
Fig. 124 Latin America market estimates and forecasts, 2018 - 2030
Fig. 125 Brazil
Fig. 126 Brazil market estimates and forecasts, 2018 - 2030
Fig. 127 Argentina
Fig. 128 Argentina market estimates and forecasts, 2018 - 2030
Fig. 129 Middle East and Africa
Fig. 130 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 131 South Africa
Fig. 132 South Africa market estimates and forecasts, 2018 - 2030
Fig. 133 Saudi Arabia
Fig. 134 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 135 UAE
Fig. 136 UAE market estimates and forecasts, 2018 - 2030
Fig. 137 Kuwait
Fig. 138 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 139 Market share of key market players- Alopecia market
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alopecia market: market outlook
Fig. 14 Alopecia competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alopecia market driver impact
Fig. 20 Alopecia market restraint impact
Fig. 21 Alopecia market strategic initiatives analysis
Fig. 22 Alopecia market: Disease type movement analysis
Fig. 23 Alopecia market: Disease type outlook and key takeaways
Fig. 24 Alopecia areata market estimates and forecast, 2018 - 2030
Fig. 25 Male alopecia areata market estimates and forecast, 2018 - 2030
Fig. 26 Female alopecia areata market estimates and forecast, 2018 - 2030
Fig. 27 Cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018 - 2030
Fig. 30 Traction alopecia market estimates and forecast, 2018 - 2030
Fig. 31 Male traction market estimates and forecast, 2018 - 2030
Fig. 32 Female traction market estimates and forecast, 2018 - 2030
Fig. 33 Alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 34 Male alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 35 Female alopecia totalis market estimates and forecast, 2018 - 2030
Fig. 36 Alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 37 Male alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 38 Female alopecia universalis market estimates and forecast, 2018 - 2030
Fig. 39 Androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018 - 2030
Fig. 42 Other alopecia market estimates and forecast, 2018 - 2030
Fig. 43 Male other alopecia market estimates and forecast, 2018 - 2030
Fig. 44 Female other alopecia market estimates and forecast, 2018 - 2030
Fig. 45 Alopecia Market: Treatment movement Analysis
Fig. 46 Alopecia market: Treatment outlook and key takeaways
Fig. 47 Pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 48 Topical market estimates and forecasts, 2018 - 2030
Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 50 Topical OTC minoxidil market estimates and forecasts, 2018 - 2030
Fig. 51 Topical OTC others market estimates and forecasts, 2018 - 2030
Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts, 2018 - 2030
Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts, 2018 - 2030
Fig. 55 Topical prescription finasteride market estimates and forecasts, 2018 - 2030
Fig. 56 Topical prescription minoxidil market estimates and forecasts, 2018 - 2030
Fig. 57 Oral pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts, 2018 - 2030
Fig. 60 Oral prescription minoxidil market estimates and forecasts, 2018 - 2030
Fig. 61 Oral prescription finasteride market estimates and forecasts, 2018 - 2030
Fig. 62 Oral prescription corticosteroids market estimates and forecasts, 2018 - 2030
Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts, 2018 - 2030
Fig. 64 PRP market estimates and forecasts, 2018 - 2030
Fig. 65 Devices market estimates and forecasts, 2018 - 2030
Fig. 66 Laser cap market estimates and forecasts, 2018 - 2030
Fig. 67 Laser comb market estimates and forecasts, 2018 - 2030
Fig. 68 Laser helmet market estimates and forecasts, 2018 - 2030
Fig. 69 Alopecia market: Gender movement analysis
Fig. 70 Alopecia market: Gender outlook and key takeaways
Fig. 71 Male market estimates and forecasts, 2018 - 2030
Fig. 72 Female market estimates and forecasts, 2018 - 2030
Fig. 73 Alopecia market: Sales channel movement analysis
Fig. 74 Alopecia market: Sales channel outlook and key takeaways
Fig. 75 Prescriptions market estimates and forecasts, 2018 - 2030
Fig. 76 OTC market estimates and forecasts, 2018 - 2030
Fig. 77 Alopecia market: End use movement analysis
Fig. 78 Alopecia market: End use outlook and key takeaways
Fig. 79 Homecare settings market estimates and forecasts, 2018 - 2030
Fig. 80 Dermatology clinics market estimates and forecasts, 2018 - 2030
Fig. 81 Global alopecia market: Regional movement analysis
Fig. 82 Global alopecia market: Regional outlook and key takeaways
Fig. 83 North America
Fig. 84 North America market estimates and forecasts, 2018 - 2030
Fig. 85 U.S.
Fig. 86 U.S. market estimates and forecasts, 2018 - 2030
Fig. 87 Canada
Fig. 88 Canada market estimates and forecasts, 2018 - 2030
Fig. 89 Mexico
Fig. 90 Mexico market estimates and forecasts, 2018 - 2030
Fig. 91 Europe
Fig. 92 Europe market estimates and forecasts, 2018 - 2030
Fig. 93 UK
Fig. 94 UK market estimates and forecasts, 2018 - 2030
Fig. 95 Germany
Fig. 96 Germany market estimates and forecasts, 2018 - 2030
Fig. 97 France
Fig. 98 France market estimates and forecasts, 2018 - 2030
Fig. 99 Italy
Fig. 100 Italy market estimates and forecasts, 2018 - 2030
Fig. 101 Spain
Fig. 102 Spain market estimates and forecasts, 2018 - 2030
Fig. 103 Denmark
Fig. 104 Denmark market estimates and forecasts, 2018 - 2030
Fig. 105 Sweden
Fig. 106 Sweden market estimates and forecasts, 2018 - 2030
Fig. 107 Norway
Fig. 108 Norway market estimates and forecasts, 2018 - 2030
Fig. 109 Asia Pacific
Fig. 110 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 111 China
Fig. 112 China market estimates and forecasts, 2018 - 2030
Fig. 113 Japan
Fig. 114 Japan market estimates and forecasts, 2018 - 2030
Fig. 115 India
Fig. 116 India market estimates and forecasts, 2018 - 2030
Fig. 117 Thailand
Fig. 118 Thailand market estimates and forecasts, 2018 - 2030
Fig. 119 South Korea
Fig. 120 South Korea market estimates and forecasts, 2018 - 2030
Fig. 121 Australia
Fig. 122 Australia market estimates and forecasts, 2018 - 2030
Fig. 123 Latin America
Fig. 124 Latin America market estimates and forecasts, 2018 - 2030
Fig. 125 Brazil
Fig. 126 Brazil market estimates and forecasts, 2018 - 2030
Fig. 127 Argentina
Fig. 128 Argentina market estimates and forecasts, 2018 - 2030
Fig. 129 Middle East and Africa
Fig. 130 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 131 South Africa
Fig. 132 South Africa market estimates and forecasts, 2018 - 2030
Fig. 133 Saudi Arabia
Fig. 134 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 135 UAE
Fig. 136 UAE market estimates and forecasts, 2018 - 2030
Fig. 137 Kuwait
Fig. 138 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 139 Market share of key market players- Alopecia market
Companies Mentioned
- Janssen Global Services Inc.
- Cipla Limited
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Sun Pharmaceuticals Industries Ltd
- Dr. Reddy’s Laboratories Ltd
- Aurobindo Pharma
- Viatris Inc.
- Pfizer, Inc.
- Lilly
- Lexington Intl., LLC (Devices)
- Freedom Laser Therapy (iRestore ID-520 helmet)
- Curallux, LLC.
- Apira Science Inc. (iGROW Laser)
- Revian Inc.
- Theradome
- Lutronic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 9.48 Billion |
| Forecasted Market Value ( USD | $ 16.02 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
